Trb Advisors LP Finch Therapeutics Group, Inc. Transaction History

Trb Advisors LP

  • $455 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021
BUY
$12.2 - $16.75 $244,000 - $335,000
20,000 Added 3.64%
570,000 $7.41 Million
Q1 2021

May 12, 2021
BUY
$15.54 - $21.32 $8.55 Million - $11.7 Million
550,000 New
550,000 $8.75 Million

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $63.4M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Trb Advisors LP Portfolio

Follow Trb Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trb Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Trb Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email